GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (OTCPK:GALDY) » Definitions » Other Stockholders Equity

GALDY (Galderma Group AG) Other Stockholders Equity : $-22 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG Other Stockholders Equity?

Galderma Group AG's Other Stockholders Equity for the quarter that ended in Dec. 2024 was $-22 Mil.

Galderma Group AG's quarterly Other Stockholders Equity increased from Dec. 2023 ($11 Mil) to Jun. 2024 ($30 Mil) but then declined from Jun. 2024 ($30 Mil) to Dec. 2024 ($-22 Mil).

Galderma Group AG's annual Other Stockholders Equity increased from . 20 ($0 Mil) to Dec. 2023 ($11 Mil) but then declined from Dec. 2023 ($11 Mil) to Dec. 2024 ($-22 Mil).

Galderma Group AG Other Stockholders Equity Historical Data

The historical data trend for Galderma Group AG's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG Other Stockholders Equity Chart

Galderma Group AG Annual Data
Trend Dec23 Dec24
Other Stockholders Equity
11.00 -22.00

Galderma Group AG Semi-Annual Data
Jun23 Dec23 Jun24 Dec24
Other Stockholders Equity - 11.00 30.00 -22.00

Galderma Group AG Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Galderma Group AG Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Galderma Group AG's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Galderma Group AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (OTCPK:GALDY) » Definitions » Other Stockholders Equity
Comparable Companies
XSWX:SDZ XSWX:SFZN XSWX:PPGN XSWX:CURN ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN HKSE:03692 NSE:DIVISLAB XTAE:TEVA ITCI SZSE:000538 UTHR BOM:500087 TSE:4507 SHSE:688506 NSE:TORNTPHARM BOM:543904
Traded in Other Exchanges
GDERF:USA GALDz:UK PY30:Germany GALD:Switzerland
Address
Zahlerweg 10, Zug, CHE, 6300
Website
https://www.galderma.com
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.